Toxin & filler authentication for the injector.
Tap the vial. Confirm it's real. Then inject.
Unit-level authentication for botulinum toxins, dermal fillers, and aesthetic devices across the medspa channel — the gap regulators leave open.
Counterfeit vials reach the clinic.
Fakes enter the chair
Counterfeit and unapproved toxins and fillers reach clinics through unofficial supply. Once a vial is in the room, the injector has no fast way to prove it is genuine.
Cold chain breaks unseen
Diverted stock travels outside the authorized chain, where temperature handling is unknown. Compromised product looks identical to product handled correctly.
Where oversight thins
The medspa channel sits between distribution and clinical practice — a seam where serialization confirms the carton but no one authenticates the individual unit.
Verify the vial before use.
Aeroz binds dual-frequency, tamper-evident, unit-level authentication to each vial and device. The injector and the patient can tap-verify it with a phone before use — no app to download.
Every check writes to an append-only audit log, and cold-chain history travels with the unit — so the check is built to flag temperature-compromised or counterfeit product.
The patient can check it too.
A tap turns trust into proof. Before injection, the patient confirms the vial is genuine and was handled inside the authorized cold chain — and the clinic holds a defensible, time-stamped record that it was.
That record protects the patient from compromised product and protects the practice if a question is ever raised.
Injectables · unit-level
Verification · network
Cold chain · custody
Every check becomes defensible data.
Authenticity events
Every clinic-side vial check and patient verification, on the record.
Tamper & seal state
Intact or breached, per vial, the moment the state changes.
Cold-chain history
Temperature excursions for heat-sensitive toxins and fillers.
Diversion intelligence
First-scan geography exposes product leaking outside the authorized channel.
Patient-verification record
Time-stamped proof the patient confirmed the unit before injection.
Custody chain
Each handoff from manufacture to chair as a unit-level event.
Verify the vial before it's drawn.
The pilot follows the product's real path: distributor intake verifies each unit on receipt, the clinic taps the vial before it's drawn, and the patient can run the same check from their own phone. Three verification points, one identity — and a counterfeit has to pass all three to reach a patient.
Unit-of-use · verified before treatment
From the Aeroz blog
- A Face Cream Recall Shows Why a Batch Number Can’t Prove a Product Is Genuine
- If Your Child Is Wearing Halloween Makeup or Contacts This Year, Read This First
- When Beauty Goes Viral, Counterfeits Follow.
More answers: Questions on standards, data carriers and NFC in the compliance FAQ
See where you're exposed — in 14 days.
A fixed-fee Aeroz audit produces a written analysis of your counterfeit and diversion exposure across the medspa channel, a vial- and device-tagging assessment, and a scoped pilot plan with cost and timeline.
What's included
- Counterfeit & diversion exposure across the medspa channel.
- Vial & device tagging assessment for injectables and hardware.
- Injector + patient verification flow design, app-free.
- Cold-chain logging scope for temperature-sensitive product.
- Pilot scope for one product line or clinic group.